218 related articles for article (PubMed ID: 24439226)
21. Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis.
Ishikawa A; Sasaki M; Ohira S; Ohta T; Oda K; Nimura Y; Chen MF; Jan YY; Yeh TS; Nakanuma Y
Lab Invest; 2004 May; 84(5):629-38. PubMed ID: 15048136
[TBL] [Abstract][Full Text] [Related]
22. Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact.
Park SY; Roh SJ; Kim YN; Kim SZ; Park HS; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS
Oncol Rep; 2009 Sep; 22(3):649-57. PubMed ID: 19639217
[TBL] [Abstract][Full Text] [Related]
23. Prognostic evaluation of mucin-5AC expression in intrahepatic cholangiocarcinoma, mass-forming type, following hepatectomy.
Abe T; Amano H; Shimamoto F; Hattori M; Kuroda S; Kobayashi T; Tashiro H; Ohdan H
Eur J Surg Oncol; 2015 Nov; 41(11):1515-21. PubMed ID: 26210654
[TBL] [Abstract][Full Text] [Related]
24. The role of S100P and IMP3 in the cytologic diagnosis of pancreatic adenocarcinoma.
Ezzat NE; Tahoun NS; Ismail YM
J Egypt Natl Canc Inst; 2016 Dec; 28(4):229-234. PubMed ID: 27839709
[TBL] [Abstract][Full Text] [Related]
25. Calcium-binding protein S100P is a novel diagnostic marker of cholangiocarcinoma.
Hamada S; Satoh K; Hirota M; Kanno A; Ishida K; Umino J; Ito H; Kikuta K; Kume K; Masamune A; Katayose Y; Unno M; Shimosegawa T
Cancer Sci; 2011 Jan; 102(1):150-6. PubMed ID: 21029254
[TBL] [Abstract][Full Text] [Related]
26. MUC1 and MUC5AC mucin expression in liver fluke-associated intrahepatic cholangiocarcinoma.
Boonla C; Sripa B; Thuwajit P; Cha-On U; Puapairoj A; Miwa M; Wongkham S
World J Gastroenterol; 2005 Aug; 11(32):4939-46. PubMed ID: 16124042
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of IMP3 and mesothelin in differentiating pancreatic ductal adenocarcinoma from chronic pancreatitis.
Ibrahim DA; Abouhashem NS
Pathol Res Pract; 2016 Apr; 212(4):288-93. PubMed ID: 26874572
[TBL] [Abstract][Full Text] [Related]
28. S100P, von Hippel-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy.
Riener MO; Kristiansen G
Hum Pathol; 2011 Sep; 42(9):1368; author reply 1368-9. PubMed ID: 21704356
[No Abstract] [Full Text] [Related]
29. Immunohistochemical Markers Distinguishing Cholangiocellular Carcinoma (CCC) from Pancreatic Ductal Adenocarcinoma (PDAC) Discovered by Proteomic Analysis of Microdissected Cells.
Padden J; Ahrens M; Kälsch J; Bertram S; Megger DA; Bracht T; Eisenacher M; Kocabayoglu P; Meyer HE; Sipos B; Baba HA; Sitek B
Mol Cell Proteomics; 2016 Mar; 15(3):1072-82. PubMed ID: 26644413
[TBL] [Abstract][Full Text] [Related]
30. Different roles of S100P overexpression in intrahepatic cholangiocarcinoma: carcinogenesis of perihilar type and aggressive behavior of peripheral type.
Aishima S; Fujita N; Mano Y; Kubo Y; Tanaka Y; Taketomi A; Shirabe K; Maehara Y; Oda Y
Am J Surg Pathol; 2011 Apr; 35(4):590-8. PubMed ID: 21412073
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical Antibody Panel for the Differential Diagnosis of Pancreatic Ductal Carcinoma From Gastrointestinal Contamination and Benign Pancreatic Duct Epithelium in Endoscopic Ultrasound-Guided Fine-Needle Aspiration.
Furuhata A; Minamiguchi S; Shirahase H; Kodama Y; Adachi S; Sakurai T; Haga H
Pancreas; 2017 Apr; 46(4):531-538. PubMed ID: 28099249
[TBL] [Abstract][Full Text] [Related]
32. Mucinous intrahepatic cholangiocarcinoma: a distinct variant.
Chi Z; Bhalla A; Saeed O; Cheng L; Curless K; Wang HL; Patil DT; Lin J
Hum Pathol; 2018 Aug; 78():131-137. PubMed ID: 29698701
[TBL] [Abstract][Full Text] [Related]
33. Prognostic role of BAP-1 and PBRM-1 expression in intrahepatic cholangiocarcinoma.
Sarcognato S; Gringeri E; Fassan M; Di Giunta M; Maffeis V; Guzzardo V; Cillo U; Guido M
Virchows Arch; 2019 Jan; 474(1):29-37. PubMed ID: 30377796
[TBL] [Abstract][Full Text] [Related]
34. Combination of MUC5ac and WT-1 immunohistochemistry is useful in distinguishing pancreatic ductal carcinoma from ovarian serous carcinoma in effusion cytology.
Han L; Pansare V; Al-Abbadi M; Husain M; Feng J
Diagn Cytopathol; 2010 May; 38(5):333-6. PubMed ID: 19856421
[TBL] [Abstract][Full Text] [Related]
35. Role of Maspin, CK17 and Ki-67 Immunophenotyping in Diagnosing of Pancreatic Ductal Adenocarcinoma in Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology.
Mamdouh MM; Okasha H; Shaaban HAM; Hafez NH; El-Gemeie EH
Asian Pac J Cancer Prev; 2021 Oct; 22(10):3299-3307. PubMed ID: 34711007
[TBL] [Abstract][Full Text] [Related]
36. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.
Abe N; Watanabe T; Izumisato Y; Suzuki Y; Masaki T; Mori T; Sugiyama M; Fusco A; Atomi Y
J Gastroenterol; 2003; 38(12):1144-9. PubMed ID: 14714251
[TBL] [Abstract][Full Text] [Related]
37. [Diagnosis and differential diagnosis of intraductal papillary mucinous neoplasm of pancreas].
Ji Y; Tan YS; Zhu XZ; Zeng HY; Kuang TT; Jin DY
Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):77-81. PubMed ID: 16630480
[TBL] [Abstract][Full Text] [Related]
38. IMP3 expression is associated with poor outcome and epigenetic deregulation in intrahepatic cholangiocarcinoma.
Gao Y; Yang M; Jiang Z; Woda BA; Mercurio AM; Qin J; Huang X; Zhang F
Hum Pathol; 2014 Jun; 45(6):1184-91. PubMed ID: 24745619
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of S100P in diagnosis of adenocarcinoma of pancreas on fine-needle aspiration biopsy specimens.
Deng H; Shi J; Wilkerson M; Meschter S; Dupree W; Lin F
Am J Clin Pathol; 2008 Jan; 129(1):81-8. PubMed ID: 18089492
[TBL] [Abstract][Full Text] [Related]
40. Novel immunohistochemical markers differentiate intrahepatic cholangiocarcinoma from benign bile duct lesions.
Bertram S; Padden J; Kälsch J; Ahrens M; Pott L; Canbay A; Weber F; Fingas C; Hoffmann AC; Vietor A; Schlaak JF; Eisenacher M; Reis H; Sitek B; Baba HA
J Clin Pathol; 2016 Jul; 69(7):619-26. PubMed ID: 26729014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
